Tech Company Financing Transactions

Ariceum Therapeutics Funding Round

Ariceum Therapeutics, based in Berlin, raised $27.4 million from Andera Partners, Earlybird Venture Capital and Pureos Bioventures.

Transaction Overview

Company Name
Ariceum Therapeutics
Announced On
4/18/2023
Transaction Type
Venture Equity
Amount
$27,410,000
Round
Series A
Investors

Andera Partners (Lead Investor) (Olivier Litzka)

Earlybird Venture Capital (Lead Investor) (Christoph Massner)

Pureos Bioventures

Proceeds Purpose
The company intends to use the funds to advance its clinical pipeline focusing on its lead asset and proprietary peptide derivative, Satoreotide, as well as building a pipeline of further projects.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Robert-Rössle-Straße. 10 Building 79
Berlin, 13125
Germany
Phone
Undisclosed
Website
www.ariceum-therapeutics.com
Email Address
[email protected]
Overview
Ariceum Therapeutics is developing novel drugs for systemic targeted radiotherapy (STR); Ariceum Therapeutics is a private clinical-stage radiopharmaceutical company focused on the diagnosis and precision treatment of neuroendocrine and certain other aggressive, hard-to-treat cancers.
Profile
Ariceum Therapeutics LinkedIn Company Profile
Social Media
Ariceum Therapeutics Company Twitter Account
Company News
Ariceum Therapeutics News
Facebook
Ariceum Therapeutics on Facebook
YouTube
Ariceum Therapeutics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Manfred Rüdiger
  Manfred Rüdiger LinkedIn Profile  Manfred Rüdiger Twitter Account  Manfred Rüdiger News  Manfred Rüdiger on Facebook
Chief Medical Officer
Alexander McEwan
  Alexander McEwan LinkedIn Profile  Alexander McEwan Twitter Account  Alexander McEwan News  Alexander McEwan on Facebook
Vice President
Ben Pais
  Ben Pais LinkedIn Profile  Ben Pais Twitter Account  Ben Pais News  Ben Pais on Facebook
VP - Operations
Tom Halliwell
  Tom Halliwell LinkedIn Profile  Tom Halliwell Twitter Account  Tom Halliwell News  Tom Halliwell on Facebook
VP - Operations
Claudio Pediconi
  Claudio Pediconi LinkedIn Profile  Claudio Pediconi Twitter Account  Claudio Pediconi News  Claudio Pediconi on Facebook

 

 

Browse more venture capital transactions:

Prev: 4/18/2023: Whisper venture capital transaction
Next: 4/18/2023: Rally Commerce venture capital transaction

 

Share this article

 

About Our VC Transactions Data

Our team works diligently to report on all VC transactions involving tech companies. VC investment data records reported here are derived from company press releases and news coverage. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.